文献速递临床试验与 GCP基础与转化研究

死亡器官捐献者环孢素A预处理对肾移植功能的影响(Cis-A-rein):随机对照试验研究方案

Effects of cyclosporine A pretreatment of deceased organ donors on kidney graft function (Cis-A-rein): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-04-17

Cis-A-rein是一项由研究者发起的多中心、前瞻性、双盲、随机对照试验,评估脑死亡捐献者接受环孢素A预处理对受者移植肾功能的影响。捐献者随机接受2.5 mg/kg环孢素A或等体积5%葡萄糖溶液,主要目标是比较两组移植后7天内需要至少一次透析的延迟移植功能(DGF)发生率。样本量648例,旨在以80%把握度检测DGF发生率10%的差异(安慰剂组30% vs 干预组20%)。

要点

  • 脑死亡捐献者接受环孢素A 2.5 mg/kg预处理,对照为等体积5%葡萄糖溶液。
  • 主要终点为移植后7天内需要至少一次透析的DGF发生率。
  • 样本量648例,基于安慰剂组30% vs 干预组20%的DGF率差异计算。

核心结论

  • 假设捐献者环孢素A早期预处理可降低肾移植受者DGF发生率,该研究方案旨在验证此假设。

研究设计与样本

  • 研究者发起的多中心、前瞻性、双盲、随机对照试验。
  • 脑死亡捐献者随机接受2.5 mg/kg环孢素A或等体积5%葡萄糖溶液。
  • 样本量n=648,按80%把握度检测两组DGF率10%差异计算。

关键数值与推荐

  • 主要终点DGF定义为移植后7天内需要至少一次透析。
  • 样本量计算假设安慰剂组DGF率30%、干预组20%。
  • 次要终点包括慢移植功能、轻度和重度DGF、移植后第一周尿量和血清肌酐、原发性移植功能障碍、1年肾功能和死亡率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Renal transplantation represents the treatment of choice of end-stage kidney disease. Delayed graft function (DGF) remains the most frequent complication after this procedure, reaching more than 30%. Its prevention is essential as it impedes early- and long-term prognosis of transplantation. Numerous pharmacological interventions aiming to prevent ischemia-reperfusion injuries failed to reduce the rate of DGF. We hypothesize that cyclosporine as an early preconditioning procedure in donors would be associated with decreased DGF. METHODS: The Cis-A-rein study is an investigator-initiated, prospective, multicenter, double-blind, randomized, controlled study performed to assess the effects of a donor preconditioning with cyclosporine A on kidney grafts function in transplanted patients. After randomization, a brain dead donor will receive 2.5 mg kg-1 of cyclosporine A or the same volume of 5% glucose solution. The primary objective is to compare the rate of DGF, defined as the need for at least one dialysis session within the 7 days following transplantation, between both groups. The secondary objectives include rate of slow graft function, mild and severe DGF, urine output and serum creatinine during the first week after transplantation, rate of primary graft dysfunction, renal function and mortality at 1 year. The sample size (n = 648) was determined to obtain 80% power to detect a 10% difference for rate of DGF at day 7 between the two groups (30% of the patients in the placebo group and 20% of the patients in the intervention group). DISCUSSION: Delayed graft function is a major issue after renal transplantation, impeding long-term prognosis. Cyclosporine A pretreatment in deceased donors could improve the outcome of patients after renal transplantation. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT02907554 Registered on 20 September 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Orban JC, Fontaine E, Cassuto E, et al. Effects of cyclosporine A pretreatment of deceased organ donors on kidney graft function (Cis-A-rein): study protocol for a randomized controlled trial. Trials. 2018. PMID: 29665840. doi:10.1186/s13063-018-2597-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。